LVRNA021
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LVRNA021, covering 2023-04-19 to 2023-11-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) [Phase 2]